1
1
1
http://www.prweb.com/releases/2009/06/prweb2522034.htm
Bioidentical Hormone Replacement Is REAL Medical Science, Not Entertainment Medicine by C.W. Randolph, Jr., M.D., Medical Director of the Natural Hormone Institute.
http://www.huffingtonpost.com/deepak-chopra/mainstream-medicine-and-t_b_213132.html
Mainstream Medicine and the Oprah Factor by Deepak Chopra. Author, Sirius radio host, founder of the Alliance for a New Humanity Posted: June 9, 2009
http://www.huffingtonpost.com/claire-shipman-and-katty-kay/did-anyone-else-think-the_b_212819.html
Did Anyone Else Think The Newsweek Photo of Oprah Was Misogynistic? And Just Plain Dumb? by Claire Shipman and Katty Kay
Newsweek decides to go the other way--withholding information seems the point. Reading this Newsweek article, you'd think there was really no difference between the synthetic hormones provided by drug companies and the bio-identical hormones that many doctors prescribe, but which are not produced by major drug companies. "They are actually synthetic, just like conventional hormones." Hardly. Yes, they are both "man-made," but the bioidenticals are created to have the same molecular structure as our own hormones. Synthetic are not, it's a one size fits all approach that leaves many women with uncomfortable side effects. The bioidentical process is quite arduous, and requires lots of testing, but each woman gets a regimen much more suited to her body.
Was anybody troubled by the glib disclosure that Newsweek correspondent Pat Wingert, who worked on this article, wrote a book on menopause? Excuse me? Talk about a dog in the fight! I imagine she can't be a big fan of bioidentical hormones in her book.
http://www.newsweek.com/id/33610
Pat Wingert. Coming to Newsweek after a nine-year journalism career in Chicago, Wingert had worked as a reporter for The Chicago Tribune from 1985 to 1986 and The Chicago Sun-Times from 1977 to 1984. While working at the Sun-Times, she worked as legman to Chicago's legendary Pulitzer-Prize winning columnist, Mike Royko. A Chicago native, Wingert received a B.S. in journalism from the University of Illinois, Champaign-Urbana. She resides in Washington D.C. with her husband Brian Kelly, the executive editor of U.S. News magazine, and their three children.
http://www.ageofautism.com/2009/06/newsweeks-newspeak-pharmas-weapon-against-oprah.html
Newsweek's Newspeak: Pharma's Weapon Against Oprah By Jake Crosby Jake Crosby is a history student at Brandeis University
"More likely, the explanation is that 10 of the 31 pages of ads are for pharma, 5 of them for Wyeth, including an inside-cover triple-page ad. Naturally, a failing magazine is going to want to receive more ad dollars by running more articles pleasing to sponsors. It seems practical and makes sense, though unethical, dishonest, defamatory and morally reprehensible all at the same time. ... Perhaps Newsweek can also run an article on the 5000 lawsuits Wyeth is facing for the damages attributed to its own, admittedly unnatural, FDA-approved version. If they did, it would help their case of proving Ms. Somers' alleged belief wrong, that "the media" is "in the pocket of the pharmaceutical industry." What matters is if Newsweek's articles fit its agenda. In a magazine filled with pharma ads, accused in 2001 by five consumer groups of breaching journalism ethics by working with the lobby group PhRMA, having a special advertising relationship with pharmaceutical corporations and allowing its publication to be used by pharma lobbyists for public relations purposes, Newsweek's agenda is no secret. One consumer advocate described Newsweek as "an infomercial masquerading as medical news" and "an example of corruption in journalism. Newsweek has surrendered its professional credentials by shamelessly engaging in disease mongering aimed at increasing profits for the mental health industry."
CONSUMER GROUPS CRITICIZE NEWSWEEK FOR TRANSGRESSING ETHICAL BOUNDS BY WORKING WITH THE PHARMACEUTICAL DRUG LOBBY
Drug Lobby's Exclusive Sponsorship of Newsweek's Special Health Edition and Other Joint Efforts Improperly Aided Drug Lobby's Agenda, Groups Claim
